期刊文献+

结肠癌血管生成拟态的形态学观察及生成机制 被引量:9

Morphology and mechanism of vasculogenic mimicry in colon carcinoma
在线阅读 下载PDF
导出
摘要 目的:探讨结肠癌血管生成拟态(VM)现象及其生成的相关机制.方法:体外三维培养结肠癌细胞株SW480,倒置显微镜下观察VM形成情况,透射电镜下观察其超微结构.采用MTT法检测磷脂酰肌醇-3激酶(PI-3K)信号通路抑制剂2-(4-吗啉基)-8-苯基-4氢-1-苯并吡喃-4-酮(LY294002)对SW480细胞的增殖抑制率.10μmo1/LLY294002处理SW480细胞72h,在光学显微镜下观察VM密度,并用逆转录聚合酶链技术(RT-PCR)检测骨桥蛋白(opn)基因,基质金属蛋白酶2(mmp2)基因水平.WesternBlot检测LY29400210μmo1/L处理SW480细胞24~72h后蛋白激酶B(PKB),磷酸化蛋白激酶B(p-PKB)蛋白的表达.结果:结肠癌细胞株SW480在体外三维培养条件下能够形成VM,电镜观察结果进一步证实了VM的存在.LY294002作用后SW480细胞的生长明显减慢,抑制率为13.01%~67.55%(P<0.01)且呈良好的时间—剂量效应关系.SW480细胞经LY29400210μmo1/L干预72h后,VM密度由(12.50±3.27)个下降至(2.60±1.07)个(P<0.01),opn,mmp2 mRNA的表达强度分别为0.31±0.01,0.20±0.04,低于未干预细胞的表达强度0.75±0.03,0.55±0.05(P<0.01).PKB蛋白表达下降(P<0.01),p-PKB蛋白表达水平无明显变化.结论:LY294002通过下调opn,mmp2mRNA的表达,抑制结肠癌细胞VM的形成,此过程与抑制PI-3K/PKB通路有关. AIM:To explore whether vasculogenic mimicry(VM)exists in colon carcinoma and the possible mechanism.METHODS:Three-dimensional culture system of human colon carcinoma cell line SW480 was constructed to observe VM under inverted microscope,and the ultrastructure of VM was observed under trans-electron microscope.The proliferation inhibitory rates of SW480 cells induced by the specific inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one(LY294002)of the signaling pathway phosphatidy1inosito1-3 kinase(PI-3K)were detected by Methyl thiazolyl tetrazolium(MTT)method.After SW480 cells were treated with LY294002 10 μmo1/L for 72 h,the density of VM was observed under light microscope.Moreover,the expressions of osteopontin(opn),matrix metalloproteinase2(mmp2)genes were assessed by reverse transcription-polymerase chain reaction(RT-PCR).After SW480 cells were treated with LY294002 10 μmo1/L for 24-72 h,the expressions of protein kinase B(PKB),phospho-protein kinase B(p-PKB)proteins were analyzed by Western Blot.RESULTS:During Three-dimensional culture,SW480 cells can form VM.The result of trans-electron microscope validated the presence of VM.After LY294002 treatment,the growth of SW480 cells was inhibited significantly in a time and dose dependent manner,and the inhibition rates were 13.01%-67.55%(P〈0.01).When treated for 72 h,The density of VM was decreased from[(12.50±3.27)to(2.60±1.07),P〈0.01],the expressions of opn,mmp2 genes were lower in LY294002 10 μmo1/L groups than in control groups[(0.31±0.01)vs(0.75±0.03),(0.20±0.04)vs(0.55±0.05),P〈0.01].The expression of p-PKB protein was down-regulated(P〈0.01),but it had no change on PKB.CONCLUSION:LY294002 can inhibit the formation of VM in colon carcinoma by reducing opn and mmp2 expression,which might be related to the inhibition of PI3K/PKB signaling pathway.
作者 田翀 高青
出处 《第四军医大学学报》 北大核心 2009年第22期2568-2571,共4页 Journal of the Fourth Military Medical University
关键词 血管生成拟态 三维培养 磷脂酰肌醇-3激酶 骨桥蛋白 基质金属蛋白酶2 vasculogenic mimicry three-dimensional culture phosphatidy1inosito1-3 kinase osteopontin matrix metalloproteinase2
  • 相关文献

参考文献4

二级参考文献50

  • 1郭瑞霞,魏丽惠.磷脂酰肌醇3激酶/蛋白激酶B信号传导通路与妇科恶性肿瘤关系的研究进展[J].中华妇产科杂志,2005,40(5):358-360. 被引量:22
  • 2侯志波,郑杰.骨桥蛋白下调对前列腺癌PC3细胞生物学行为的影响[J].肿瘤,2005,25(6):542-546. 被引量:4
  • 3Gao J,Flynn DC,Bellone S,et al.G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells[J].Am J Physiol Cell Physiol,2004,287:281-291.
  • 4Levine D,Bogomolniy F,Yee C,et al.Frequent mutation of gene PI3KCA in ovarian and breast cancers[J].Clin Cancer Res,2005,11:2875-2878.
  • 5Cheng J,Chou C,Kuo M,et al.Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway[J].Oncogene,2006,25:7009-7018.
  • 6Fresno A,Casado E,Castro J,et al.PI3K/Akt signaling pathway and cancer[J].Cancer Treat,2004,30:193-204.
  • 7Vivanco I,Sawyers C.The phosphatidylinositol 3-Kinase AKT pathway in human cancer[J].Nat Rev Cancer,2002,2:489-501.
  • 8WAI P Y, MI Z, GUO H, et al. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT 26 murine colon adenocarcinoma metastasis [ J ]. Carcinogenesis, 2005, 26 ( 4 ) : 741-751.
  • 9HIRAMA M, TAKAHASHI F, TAKAHASHI K, et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth [ J ]. Cancer Lett, 2003, 198 ( 1 ) : 107-117.
  • 10EL-TANANI M K, CAMPBELL F C, KURISETTY V, et al. The regulation and role of osteopontin in malignant transformation and cancer[ J ]. Cytokine Growth Factor Rev, 2006, 17 (6) :463-474.

共引文献26

同被引文献104

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部